Company Filing History:
Years Active: 2025
Title: The Innovations of Manway Liu: A Pioneer in Multi-Omic Assessment
Introduction
Manway Liu is an accomplished inventor based in Burlingame, CA, renowned for his contributions to the field of biomolecular analysis. With two patents to his name, Liu has demonstrated a keen ability to develop innovative solutions that enhance our understanding of complex biological datasets.
Latest Patents
Manway Liu's latest innovations include significant advancements in the classification and assessment of biomolecules. His first patent, titled "Direct Classification of Raw Biomolecule Measurement Data," encompasses systems and methods designed for the direct classification of biological datasets. This includes raw mass spectrometry data and involves training classifiers to apply these techniques effectively.
His second patent, "Multi-Omic Assessment Using Proteins and Nucleic Acids," introduces novel methods for evaluating diseases, particularly cancer. The multi-omic methods encompass various data types, including proteomic, transcriptomic, genomic, lipidomic, and metabolomic data, facilitating comprehensive disease screening from biological samples.
Career Highlights
Manway Liu is currently leveraging his expertise at Prognomiq, Inc., where he applies his skills in biomolecular analysis and contributes to cutting-edge research. His pioneering work addresses the urgent need for innovative methodologies in disease assessment, further establishing him as a key player in the biomedical field.
Collaborations
Throughout his career, Liu has collaborated with esteemed colleagues such as Philip Ma and Chinmay Belthangady. Together, they work towards harnessing their collective expertise to drive advancements in biomolecular research and development.
Conclusion
In summary, Manway Liu stands out as a notable inventor whose work is paving the way for groundbreaking advancements in the analysis of biological datasets and disease assessment. His contributions through innovative patents significantly impact the medical and research communities, illustrating his dedication to improving healthcare outcomes.